Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study
Authors:
- 3 August 2010
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 12 (1) , 62-67
Abstract
In two previous studies we found an association between HTR2C polymorphisms and the prevalence of the metabolic syndrome in patients using antipsychotics. In this study, we set out to replicate our findings in a third separate sample of patients. Data for this cross-sectional study came from the ongoing Pharmacotherapy Monitoring and Outcome survey study, investigating the association between schizophrenia and metabolic or cardiovascular risk factors. Primary end point was the prevalence of the metabolic syndrome. Primary determinants were two polymorphisms in the HTR2C gene: rs3813929 (−759 C/T) and rs1414334:C>G. Carriership of the variant rs1414334 C-allele was significantly associated with an increase prevalence of the metabolic syndrome (odds ratio (OR) 3.73; 95% confidence interval (CI) 1.29–10.79, P=0.015). No association was found between the HTR2C −759 C/T polymorphism and the metabolic syndrome. This study confirms previous findings that the variant C-allele of the rs1414334 polymorphism is associated with the metabolic syndrome.Keywords
This publication has 23 references indexed in Scilit:
- Prevalence of Metabolic Syndrome in Patients With Psychotic Disorders in the NetherlandsJournal of Clinical Psychopharmacology, 2009
- Identifying people with metabolic syndrome in primary care by screening with a mailed tape measurePreventive Medicine, 2009
- HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With SchizophreniaJournal of Clinical Psychopharmacology, 2009
- Lack of association between the −759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patientsJournal of Clinical Pharmacy and Therapeutics, 2008
- The Association Between HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With SchizophreniaJournal of Clinical Psychopharmacology, 2007
- Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysisInternational Journal of Neuropsychopharmacology, 2007
- Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES IIISchizophrenia Research, 2005
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapineAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptorsNature, 1995